Lipid Market Size, Share & Trends Analysis Report By Product (Triglycerides, Phospholipids), By Phase (Clinical, Pre-clinical), By Application, By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within Immediate
Lipid Market Growth & Trends
The global lipid market is expected to reach USD 12.85 billion by 2030, as per the new report by Grand View Research, Inc. The growth is majorly driven by the rising utilization of lipids in the production of functional food, functional beverages, and dietary supplements owing to their rich properties such as high in energy. In the human body, lipids are used for protecting nerve cells, supporting cells and other essential functions, supplying vitamins to the body, producing hormones such as testosterone, estrogen, and cortisol, etc., which is expected to propel the demand for lipids over the projected years globally.
Ionizable lipids have been growing due to its increasing use in the pharmaceutical industry due to their high efficiency in delivering therapeutics. During COVID-19, it was widely used for transferring mRNA to cells. These above-mentioned factors are attributed to the growth of the lipid nanoparticle market.
Population growth in the Asia Pacific has been a key factor for the steady pace of growth of industries in the region. Rising consumption of consumer products, healthcare products, food & beverages products, and others has augmented the demand for chemical ingredients in the region. In addition, the region has the presence of major market players, such as Cargill Incorporated, BASF SE, and Kerry Group plc, which have been producing lipids in large volumes to fulfill the requirements in the region.
China is the most populous country in the world with population of approximately 1.42 billion. Rising population of China has propelled the consumption of food & beverages and nutritional supplements in the country. Chinese consumers are more inclined toward functional beverages that contain ingredients beneficial to health. This factor is expected to augment the demand for lipids in the manufacturing of food & beverages in China over the projected years.
The easy availability of sources such as plants and animals has resulted in an increased number of suppliers of raw materials used for developing fatty acids across the world. This high number of raw material suppliers results in intense competition in the market, thereby leading to an inconsistency in prices and availability of raw materials.
The spread of COVID-19 positively impacted the growth of the lipid market across the world. The massive health crisis worldwide during the pandemic fueled the demand for dietary supplements and medicines. Furthermore, its consumption in the pharmaceuticals industry, particularly for the formulation of the COVID-19 vaccines, enhanced its demand during the pandemic.
Lipid Market Report Highlights
Lipid Market Growth & Trends
The global lipid market is expected to reach USD 12.85 billion by 2030, as per the new report by Grand View Research, Inc. The growth is majorly driven by the rising utilization of lipids in the production of functional food, functional beverages, and dietary supplements owing to their rich properties such as high in energy. In the human body, lipids are used for protecting nerve cells, supporting cells and other essential functions, supplying vitamins to the body, producing hormones such as testosterone, estrogen, and cortisol, etc., which is expected to propel the demand for lipids over the projected years globally.
Ionizable lipids have been growing due to its increasing use in the pharmaceutical industry due to their high efficiency in delivering therapeutics. During COVID-19, it was widely used for transferring mRNA to cells. These above-mentioned factors are attributed to the growth of the lipid nanoparticle market.
Population growth in the Asia Pacific has been a key factor for the steady pace of growth of industries in the region. Rising consumption of consumer products, healthcare products, food & beverages products, and others has augmented the demand for chemical ingredients in the region. In addition, the region has the presence of major market players, such as Cargill Incorporated, BASF SE, and Kerry Group plc, which have been producing lipids in large volumes to fulfill the requirements in the region.
China is the most populous country in the world with population of approximately 1.42 billion. Rising population of China has propelled the consumption of food & beverages and nutritional supplements in the country. Chinese consumers are more inclined toward functional beverages that contain ingredients beneficial to health. This factor is expected to augment the demand for lipids in the manufacturing of food & beverages in China over the projected years.
The easy availability of sources such as plants and animals has resulted in an increased number of suppliers of raw materials used for developing fatty acids across the world. This high number of raw material suppliers results in intense competition in the market, thereby leading to an inconsistency in prices and availability of raw materials.
The spread of COVID-19 positively impacted the growth of the lipid market across the world. The massive health crisis worldwide during the pandemic fueled the demand for dietary supplements and medicines. Furthermore, its consumption in the pharmaceuticals industry, particularly for the formulation of the COVID-19 vaccines, enhanced its demand during the pandemic.
Lipid Market Report Highlights
- Triglycerides is the fastest growing product segment with a CAGR of 8.9% from 2022 to 2030 on the account of its rising application in food & beverages industry for the formulation of functional food and functional beverages
- Food & beverages application is the fastest growing segment with a CAGR of 8.9% from 2022 to 2030 owing to the increasing consumption of food on the account of rising population
- Asia Pacific is the fastest growing region with a CAGR of 9.2% because of the increasing consumption in functional food, dietary supplements, and medicines in the countries like China and India owing to the increasing population
- The presence of government regulations related to the production and consumption of lipids in different countries owing to the usage of plants and animals for developing them is anticipated to hinder the growth of the market over the foreseeable future
- The ongoing European geopolitical conflict between Russia and Ukraine has led to a hike in the costs of oil, energy, natural gas, etc. This situation has resulted in the price hike of raw materials for lipid production
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation & Scope
1.2 Market Definition
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Third Party Perspective
1.3.5 Primary Research
1.3.6 Primary Sources
1.4 Information Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Data Visualization
1.6 Data Validation & Publishing
1.7 Research Scope And Assumptions
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segmental Outlook
2.3 Competitive Insights
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Global Lipid Market
3.2 Penetration & Growth Prospect Mapping
3.3 Industry Value Chain Analysis
3.3.1 Raw Material Trends
3.3.2 Manufacturing/Technology Trends
3.3.3 Sales Channel Analysis
3.4 Supply-Demand Analysis
3.4.1 Supply
3.4.2 Demand
3.5 Regulatory Framework
3.6 Price Trend Analysis, 2018 - 2030
3.7 Market Dynamics
3.7.1 Market Driver Impact Analysis
3.7.1.1 Growing Global Demand For Dietary Supplements Owing To Rising Health Concerns
3.7.2 Increasing Usage Of Lipids In Various Applications Due To Their Superior Functional Properties
3.7.3 Market Restraint Impact Analysis
3.7.3.1 Volatile Feedstock Prices
3.7.4 Industry Challenges
3.8 Impact Of COVID-19 On The Industry
3.9 Impact Of Eastern European Geopolitical Conflict On The Industry
3.10 Production Cost Analysis
3.11 Opportunities Of Nano Lipids In Pharmaceutical
3.12 Business Environment Analysis
3.12.1 Porter’s Analysis
3.12.2 PESTEL Analysis
CHAPTER 4 LIPID MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1 Product Movement Analysis & Market Share, 2021 & 2030 (Kilotons) (USD Million)
4.1.1 Ionizable Lipids (Lipid Nano Particles)
4.1.1.1 mRNA
4.1.1.2 siRNA
4.1.1.3 Others
4.1.2 Triglycerides
4.1.3 Sphingolipids
4.1.4 Phospholipids
4.1.5 Others (Neutral Lipids, Pegylated Lipids)
CHAPTER 5 LIPID MARKET: PHASE ESTIMATES & TREND ANALYSIS
5.1 Phase Movement Analysis & Market Share, 2021 & 2030 (Kilotons) (USD Million)
5.1.1 Clinical Phase
5.1.2 Pre-Clinical Phase
5.1.3 Others
CHAPTER 6 LIPID MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
6.1 Application Movement Analysis & Market Share, 2021 & 2030 (Kilotons) (USD Million)
6.1.1 Pharmaceuticals
6.1.1.1 Vaccines And Drugs
6.1.1.2 Scientific Research
6.1.2 Nutrition & Supplements
6.1.3 Food & Beverages
6.1.4 Others
CHAPTER 7 LIPID MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1 Regional Movement Analysis & Market Share, 2021 & 2030 (Kilotons) (USD Million)
7.1.1 North America
7.1.1.1 U.S.
7.1.1.2 Canada
7.1.1.3 Mexico
7.1.2 Europe
7.1.2.1 Germany
7.1.2.2 UK
7.1.2.3 France
7.1.2.4 Spain
7.1.2.5 Italy
7.1.2.6 Belgium
7.1.2.7 Russia
7.1.2.8 Turkey
7.1.3 Asia Pacific
7.1.3.1 China
7.1.3.2 India
7.1.3.3 Japan
7.1.3.4 Australia
7.1.3.5 Indonesia
7.1.3.6 Thailand
7.1.3.7 Philippines
7.1.3.8 Malaysia
7.1.3.9 Vietnam
7.1.3.10 South Korea
7.1.4 Central & South America
7.1.4.1 Brazil
7.1.4.2 Argentina
7.1.4.3 Colombia
7.1.5 Middle East & Africa
7.1.5.1 Saudi Arabia
7.1.5.2 South Africa
7.1.5.3 U.A.E.
7.1.5.4 Egypt
7.1.5.5 Nigeria
CHAPTER 8 LIPID MARKET - COMPETITIVE LANDSCAPE
8.1 Recent Developments & Impact Analysis, By Key Market Participants
8.2 Company/Competition Categorization (Key Innovators, Market Leaders, And Emerging Players)
8.3 Vendor Landscape
8.3.1 List Of Raw Material Suppliers
8.3.2 List Of Manufacturers
8.3.3 List Of Key Distributors And Channel Partners
8.3.4 List Of Potential Endusers
8.4 Key Company Market Positioning Analysis, 2021
8.5 Strategic Framework
CHAPTER 9 COMPANY PROFILES
9.1 Evonik Industries AG
9.1.1 Company Overview
9.1.2 Financial Performance
9.1.3 Product Benchmarking
9.1.4 Strategic Initiatives
9.2 Precision Nanosystems
9.2.1 Company Overview
9.2.2 Financial Performance
9.2.3 Product Benchmarking
9.2.4 Strategic Initiatives
9.3 Merck Kgaa
9.3.1 Company Overview
9.3.2 Financial Performance
9.3.3 Product Benchmarking
9.3.4 Strategic Initiatives
9.4 Genevant Sciences
9.4.1 Company Overview
9.4.2 Financial Performance
9.4.3 Product Benchmarking
9.4.4 Strategic Initiatives
9.5 Exelead
9.5.1 Company Overview
9.5.2 Financial Performance
9.5.3 Product Benchmarking
9.5.4 Strategic Initiatives
9.6 Avanti Polar Lipids
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Product Benchmarking
9.6.4 Strategic Initiatives
9.7 Nippon Fine Chemicals Co. Ltd.
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Product Benchmarking
9.8 Lipoid Gmbh
9.8.1 Company Overview
9.8.2 Financial Performance
9.8.3 Product Benchmarking
9.8.4 Strategic Initiatives
9.9 Cargill, Incorporated
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Product Benchmarking
9.9.4 Strategic Initiatives
9.10 BASF SE
9.10.1 Company Overview
9.10.2 Financial Performance
9.10.3 Product Benchmarking
9.10.4 Strategic Initiatives
9.11 Archer Daniels Midland Company (ADM)
9.11.1 Company Overview
9.11.2 Financial Performance
9.11.3 Product Benchmarking
9.11.4 Strategic Initiatives
9.12 Koninklijke DSM N.V.
9.12.1 Company Overview
9.12.2 Financial Performance
9.12.3 Product Benchmarking
9.12.4 Strategic Initiatives
9.13 Kerry Group Plc
9.13.1 Company Overview
9.13.2 Financial Performance
9.13.3 Product Benchmarking
9.13.4 Strategic Initiatives
9.14 Nordic Naturals, Inc.
9.14.1 Company Overview
9.14.2 Financial Performance
9.14.3 Product Benchmarking
9.14.4 Strategic Initiatives
9.15 Clover Corporation
9.15.1 Company Overview
9.15.2 Financial Performance
9.15.3 Product Benchmarking
9.16 Croda International Plc
9.16.1 Company Overview
9.16.2 Financial Performance
9.16.3 Product Benchmarking
9.16.4 Strategic Initiatives
9.17 Lipoid Kosmetik AG
9.17.1 Company Overview
9.17.2 Financial Performance
9.17.3 Product Benchmarking
9.17.4 Strategic Initiatives
9.18 Omega Protein Corporation
9.18.1 Company Overview
9.18.2 Financial Performance
9.18.3 Product Benchmarking
1.1 Market Segmentation & Scope
1.2 Market Definition
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Third Party Perspective
1.3.5 Primary Research
1.3.6 Primary Sources
1.4 Information Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Data Visualization
1.6 Data Validation & Publishing
1.7 Research Scope And Assumptions
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segmental Outlook
2.3 Competitive Insights
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Global Lipid Market
3.2 Penetration & Growth Prospect Mapping
3.3 Industry Value Chain Analysis
3.3.1 Raw Material Trends
3.3.2 Manufacturing/Technology Trends
3.3.3 Sales Channel Analysis
3.4 Supply-Demand Analysis
3.4.1 Supply
3.4.2 Demand
3.5 Regulatory Framework
3.6 Price Trend Analysis, 2018 - 2030
3.7 Market Dynamics
3.7.1 Market Driver Impact Analysis
3.7.1.1 Growing Global Demand For Dietary Supplements Owing To Rising Health Concerns
3.7.2 Increasing Usage Of Lipids In Various Applications Due To Their Superior Functional Properties
3.7.3 Market Restraint Impact Analysis
3.7.3.1 Volatile Feedstock Prices
3.7.4 Industry Challenges
3.8 Impact Of COVID-19 On The Industry
3.9 Impact Of Eastern European Geopolitical Conflict On The Industry
3.10 Production Cost Analysis
3.11 Opportunities Of Nano Lipids In Pharmaceutical
3.12 Business Environment Analysis
3.12.1 Porter’s Analysis
3.12.2 PESTEL Analysis
CHAPTER 4 LIPID MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1 Product Movement Analysis & Market Share, 2021 & 2030 (Kilotons) (USD Million)
4.1.1 Ionizable Lipids (Lipid Nano Particles)
4.1.1.1 mRNA
4.1.1.2 siRNA
4.1.1.3 Others
4.1.2 Triglycerides
4.1.3 Sphingolipids
4.1.4 Phospholipids
4.1.5 Others (Neutral Lipids, Pegylated Lipids)
CHAPTER 5 LIPID MARKET: PHASE ESTIMATES & TREND ANALYSIS
5.1 Phase Movement Analysis & Market Share, 2021 & 2030 (Kilotons) (USD Million)
5.1.1 Clinical Phase
5.1.2 Pre-Clinical Phase
5.1.3 Others
CHAPTER 6 LIPID MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
6.1 Application Movement Analysis & Market Share, 2021 & 2030 (Kilotons) (USD Million)
6.1.1 Pharmaceuticals
6.1.1.1 Vaccines And Drugs
6.1.1.2 Scientific Research
6.1.2 Nutrition & Supplements
6.1.3 Food & Beverages
6.1.4 Others
CHAPTER 7 LIPID MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1 Regional Movement Analysis & Market Share, 2021 & 2030 (Kilotons) (USD Million)
7.1.1 North America
7.1.1.1 U.S.
7.1.1.2 Canada
7.1.1.3 Mexico
7.1.2 Europe
7.1.2.1 Germany
7.1.2.2 UK
7.1.2.3 France
7.1.2.4 Spain
7.1.2.5 Italy
7.1.2.6 Belgium
7.1.2.7 Russia
7.1.2.8 Turkey
7.1.3 Asia Pacific
7.1.3.1 China
7.1.3.2 India
7.1.3.3 Japan
7.1.3.4 Australia
7.1.3.5 Indonesia
7.1.3.6 Thailand
7.1.3.7 Philippines
7.1.3.8 Malaysia
7.1.3.9 Vietnam
7.1.3.10 South Korea
7.1.4 Central & South America
7.1.4.1 Brazil
7.1.4.2 Argentina
7.1.4.3 Colombia
7.1.5 Middle East & Africa
7.1.5.1 Saudi Arabia
7.1.5.2 South Africa
7.1.5.3 U.A.E.
7.1.5.4 Egypt
7.1.5.5 Nigeria
CHAPTER 8 LIPID MARKET - COMPETITIVE LANDSCAPE
8.1 Recent Developments & Impact Analysis, By Key Market Participants
8.2 Company/Competition Categorization (Key Innovators, Market Leaders, And Emerging Players)
8.3 Vendor Landscape
8.3.1 List Of Raw Material Suppliers
8.3.2 List Of Manufacturers
8.3.3 List Of Key Distributors And Channel Partners
8.3.4 List Of Potential Endusers
8.4 Key Company Market Positioning Analysis, 2021
8.5 Strategic Framework
CHAPTER 9 COMPANY PROFILES
9.1 Evonik Industries AG
9.1.1 Company Overview
9.1.2 Financial Performance
9.1.3 Product Benchmarking
9.1.4 Strategic Initiatives
9.2 Precision Nanosystems
9.2.1 Company Overview
9.2.2 Financial Performance
9.2.3 Product Benchmarking
9.2.4 Strategic Initiatives
9.3 Merck Kgaa
9.3.1 Company Overview
9.3.2 Financial Performance
9.3.3 Product Benchmarking
9.3.4 Strategic Initiatives
9.4 Genevant Sciences
9.4.1 Company Overview
9.4.2 Financial Performance
9.4.3 Product Benchmarking
9.4.4 Strategic Initiatives
9.5 Exelead
9.5.1 Company Overview
9.5.2 Financial Performance
9.5.3 Product Benchmarking
9.5.4 Strategic Initiatives
9.6 Avanti Polar Lipids
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Product Benchmarking
9.6.4 Strategic Initiatives
9.7 Nippon Fine Chemicals Co. Ltd.
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Product Benchmarking
9.8 Lipoid Gmbh
9.8.1 Company Overview
9.8.2 Financial Performance
9.8.3 Product Benchmarking
9.8.4 Strategic Initiatives
9.9 Cargill, Incorporated
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Product Benchmarking
9.9.4 Strategic Initiatives
9.10 BASF SE
9.10.1 Company Overview
9.10.2 Financial Performance
9.10.3 Product Benchmarking
9.10.4 Strategic Initiatives
9.11 Archer Daniels Midland Company (ADM)
9.11.1 Company Overview
9.11.2 Financial Performance
9.11.3 Product Benchmarking
9.11.4 Strategic Initiatives
9.12 Koninklijke DSM N.V.
9.12.1 Company Overview
9.12.2 Financial Performance
9.12.3 Product Benchmarking
9.12.4 Strategic Initiatives
9.13 Kerry Group Plc
9.13.1 Company Overview
9.13.2 Financial Performance
9.13.3 Product Benchmarking
9.13.4 Strategic Initiatives
9.14 Nordic Naturals, Inc.
9.14.1 Company Overview
9.14.2 Financial Performance
9.14.3 Product Benchmarking
9.14.4 Strategic Initiatives
9.15 Clover Corporation
9.15.1 Company Overview
9.15.2 Financial Performance
9.15.3 Product Benchmarking
9.16 Croda International Plc
9.16.1 Company Overview
9.16.2 Financial Performance
9.16.3 Product Benchmarking
9.16.4 Strategic Initiatives
9.17 Lipoid Kosmetik AG
9.17.1 Company Overview
9.17.2 Financial Performance
9.17.3 Product Benchmarking
9.17.4 Strategic Initiatives
9.18 Omega Protein Corporation
9.18.1 Company Overview
9.18.2 Financial Performance
9.18.3 Product Benchmarking
LIST OF TABLES
Table 1 Key Company/Competition Categorization
Table 2 List Of Key Raw Material Suppliers
Table 3 List Of Manufacturers
Table 4 List Of Key Distributors And Channel Partners
Table 5 List Of Potential End Users
Table 1 Key Company/Competition Categorization
Table 2 List Of Key Raw Material Suppliers
Table 3 List Of Manufacturers
Table 4 List Of Key Distributors And Channel Partners
Table 5 List Of Potential End Users
LIST OF FIGURES
Fig. 1 Lipid Market Segmentation
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Data Analysis Models
Fig. 5 Market Formulation And Validation
Fig. 6 Data Validating & Publishing
Fig. 7 Market Snapshot, 2021
Fig. 8 Structural Adhesives Market, Segmental Outlook, 2021 (USD Million)
Fig. 9 Global Lipid Market Volume & Revenue, 2018 - 2030 (Kilotons) (USD Million)
Fig. 10 Global Lipid Market Value Chain Analysis
Fig. 11 Lipid Market Dynamics
Fig. 12 Market Driver Analysis
Fig. 13 Global Dietary Supplements Market, 2017 - 2021 (USD Million)
Fig. 14 Market Restraint Analysis
Fig. 15 Lipid Market: Porter’s Analysis
Fig. 16 Lipid Market: PESTEL Analysis
Fig. 17 Lipid Market Revenue Share, By Product, 2021 & 2030 (%)
Fig. 18 Lipid Market Revenue Share, By Phase, 2021 & 2030 (%)
Fig. 19 Lipid Market Revenue Share, By Application, 2021 & 2030 (%)
Fig. 20 Lipid Market Revenue Share, By Region, 2021 & 2030 (%)
Fig. 21 Mexico Pharmaceuticals Market Size , 2016 - 2021 (in USD Million)
Fig. 22 Lipid Market: Positioning Analysiss
Fig. 23 Strategic Framework
Fig. 1 Lipid Market Segmentation
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Data Analysis Models
Fig. 5 Market Formulation And Validation
Fig. 6 Data Validating & Publishing
Fig. 7 Market Snapshot, 2021
Fig. 8 Structural Adhesives Market, Segmental Outlook, 2021 (USD Million)
Fig. 9 Global Lipid Market Volume & Revenue, 2018 - 2030 (Kilotons) (USD Million)
Fig. 10 Global Lipid Market Value Chain Analysis
Fig. 11 Lipid Market Dynamics
Fig. 12 Market Driver Analysis
Fig. 13 Global Dietary Supplements Market, 2017 - 2021 (USD Million)
Fig. 14 Market Restraint Analysis
Fig. 15 Lipid Market: Porter’s Analysis
Fig. 16 Lipid Market: PESTEL Analysis
Fig. 17 Lipid Market Revenue Share, By Product, 2021 & 2030 (%)
Fig. 18 Lipid Market Revenue Share, By Phase, 2021 & 2030 (%)
Fig. 19 Lipid Market Revenue Share, By Application, 2021 & 2030 (%)
Fig. 20 Lipid Market Revenue Share, By Region, 2021 & 2030 (%)
Fig. 21 Mexico Pharmaceuticals Market Size , 2016 - 2021 (in USD Million)
Fig. 22 Lipid Market: Positioning Analysiss
Fig. 23 Strategic Framework
